Rối loạn nhịp thất ở bệnh nhân đặt máy tạo nhịp tái đồng bộ tim
Tóm tắt
Rối loạn nhịp thất ở bệnh nhân đặt máy tạo nhịp tái đồng bộ timTài liệu tham khảo
1. Auricchio A, Stellbrink C et al. Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study group. Long term clinical effect of hymodynamically optimized cardiac resynchronization therapy in pts with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002; 39:2026-2033.
2. Auricchio A, Stellbrink C et al. Pacing Therapies in Congestive Heart Failure II (PATH-CHF) Study group. Guiant Heart Failure Reseach Group. Clinical effecacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 2003; 42:2109-2116.
3. Abraham WT, Fisher WG et al. MIRACLE study group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346:1845-1853.
4. Abraham WT, Young JB et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.. Circulation 2004;110:2864-8
5. Bristow MR, Saxon LA et al. Comparision of Medical Therapy, Pacing and Defibrilation in Heart Failure (COMPANION) Investigators. Cardiac resynchronization therapy with and without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350: 2140-2150
6. Cazeau S, Leclercq C et al. Multisite Stimulation in Cardiomyopathies (MUSTIC) study investigators. Effects of multisite biventricularpacing in pts with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-880.
7. Cleland JG, Daubert JC et al. Cardiac Resynchronization- Heart Failure (CARE-HF) study investigators. The effect on cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2003;352;1539-1549.
8. Linde C, Leclerq C et al. Long term benefirs of biventricular pacing in congestive heart failure: Results from the MUltisite STimulation in cardiacmyopathy (MUSTIC) study. J Am Coll Cardiol . 2002;40:111- 118.
9. Lozano I, Bocchiardo M et al. VENTAK CHF/CONTAK CD Investigators study group. Impact of biventricualr pacing on mortality in a randomized crossover study of pts with heart failure and ventricular arrhythmias. PACE 2000; 23:1711-1712.
10. Young JB, Abraham WT et al. Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrilation in advanced chronic heart failure: MIRACLE-ICD Trial. JAMA 2003;289:2685-2694
11. Leclercq C, Walker S, Linde C, Clementy J et al. Comparative effects of permanent biventricular and right- univentricular pacing in heart failure patients with chronic atrial fibrillation.. Eur Heart J 2002;23:1780-7.
12. Higgins SL, Hummel JD, Niazi IK et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias.. J Am Coll Cardiol 2003;42:1454-9.
13. Garrigue S, Bordachar P, Reuter S et al. Comparison of permanent left ventricular and biventricular pacing in patients with heart failure and chronic atrial fibrillation: prospective haemodynamic study.. Heart 2002;87:529-34
14. Linde C, Abraham WT, Gold MR et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.. J Am Coll Cardiol 2008;52:1834-43.
15. Moss AJ, Hall WJ, Cannom DS et al. Cardiac-Resynchronization Therapy for the Prevention of Heart- Failure Events. NEJM 2009;361: 1329-1338.
16. Ermis C, Seutter R Zhu A et al. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia in pts with implantable cardioverter defibrillators. J Am Coll Cardiol 2005;46:2258-63.
17. Mc Swain R, Schwartz R, Delurgio D et al. The impact of cardiac resynchronization therapy on ventricular tachycardia/fibrillation: an analysis from the combined Contack CD and Insync_ICD studies. JCardiovasc Electrophysiol 2005;16:1168-71.
18. Higgins S, Yuong P, Scheck D et al. Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000;36:824-7.
19. Kies P, Bax J , Molhoek S et al. Effect of left ventricular remodeling after cardiac resynchronization therapy on frequency of ventricular arrhythmias. Am J Cardiol 2004;94:130-2.
20. DiCori A, Bongiorni M Arena G et al. New onset ventricular tachycardia after cardiac resynchronization therapy. J Interv Card Electrophysiol 2005; 12:231-5.
21. Guerra J, Wu J, Meller J et al. Increase in ventricular tachycardia frequency after biventricular impkantable cardioverter defibrillator upgrade. J Cardiovasc Electrophysiol 2003;14:1245-7.
22. Hjalmarson A, Goldstein S, Fagerberg B, et al, for the MERIT-HF Study Group. Effects of controlled- release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). JAMA 2000; 283: 1295-1302.
23. Bardy GH, Lee KL et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. NEJM
; 352: 225-37.
24. Epstein EA, DiMarco JP et al. ACC/AHA/HRS 2008 guidelines for Device-Based therapy of cardiac Rhythm Abnormalities.; JACC ; 2008;21:1-62.
25. Dickstein K, Vardas P et al. 2010 ESC guideline on device therapy in heart failure. Eur Heart J 2010; 31:203-210.
26. Ph¹m Nh Hïng, §ç Kim B¶ng, T¹ TiÕn Phíc. §iÒu trÞ suy tim nÆng b»ng m¸y t¹o nhÞp t¸i ®ång bé tim.
Y häc l©m sµng 2010; 64-69.
27. The Antiarrhythmics Vs Implantable Defibrillator (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-83.
28. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS): a randomized
trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101:1297-302.
29. Kuck KH, Cappato R, Siebels J, Rüppel. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102(7):748-54
30. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follman D, Gent M, Roberts RS. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. Eur Heart J. 2000;21(24):2071- 8.
31. Julian DG, Camm AJ, Frangin G, et al. Randomized trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997; 349:667-74.
32. Cairns JA, Connolly SJ, Roberts R, et al. for the Canadian Myocardial Infarction Arrhythmia Trial Investigators. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT. Lancet 1997; 349:675-82.
33. Eleanor B. Schron, Derek V. Exner, Quality of Life in the Antiarrhythmics Versus implantable Defibrillators Trial: impact of Therapy and influence of Adverse Symptoms and Defibrillator Shocks. Circulation. 2002;105:589-594
34. Maury P, Nault i, Sacher F.202 Late Outcome of Radio-frequency ablation for monomorphic sustained Ventricular tachycardia in patients with underlying heart disease without implantation of a defibrillator. Archives of Cardiovascular Diseases Supplements 2010; 2: 64-70.
35. Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007;357:2657-2665.
